
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated November 02, 2023, titled "SPARC enters into an exclusive worldwide license agreement for SCD-153 with JHU and IOCB ".
Filed with NSE ·

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated November 02, 2023, titled "SPARC enters into an exclusive worldwide license agreement for SCD-153 with JHU and IOCB ".
6ix hasn’t read this filing yet.
Sun Pharma Advanced Research Co. Ltd. on 6ix
Follow Sun Pharma Advanced Research into a list and get an email when it puts out news.
Follow Sun Pharma Advanced Research